The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. (18th April 2017) - McCarthy, Eoghan M.; Sutton, Emily; Nesbit, Stephanie; Parker, Ben; Jayne, David; Griffiths, Bridget; Isenberg, David A.; Rahman, Anisur; Gordon, Caroline; D'Cruz, David P.; Rhodes, Benjamin; Lanyon, Peter; et al.